SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 19th, 2021 • Beam Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 19th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 16, 2021 (the “Effective Date”), among Beam Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”).